{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:26:25Z","timestamp":1791069985580,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.cbi.2011.01.024","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T04:18:20Z","timestamp":1296188300000},"page":"357-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE)"],"prefix":"10.1016","volume":"191","author":[{"given":"Shahid P.","family":"Baba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruni","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2011.01.024_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.46.1.223","article-title":"Advanced protein glycosylation in diabetes and aging","volume":"46","author":"Brownlee","year":"1995","journal-title":"Annu. Rev. Med."},{"issue":"2","key":"10.1016\/j.cbi.2011.01.024_bib0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: a review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.cbi.2011.01.024_bib0015","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI119853","article-title":"Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy","volume":"100","author":"Horie","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.cbi.2011.01.024_bib0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1172\/JCI119180","article-title":"Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging","volume":"99","author":"Schleicher","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.cbi.2011.01.024_bib0025","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0002-9440(10)63225-7","article-title":"Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1\/2 MAP kinase signaling pathway","volume":"164","author":"Li","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.cbi.2011.01.024_bib0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00109-009-0439-2","article-title":"Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response","volume":"87","author":"Yan","year":"2009","journal-title":"J. Mol. Med."},{"issue":"5","key":"10.1016\/j.cbi.2011.01.024_bib0035","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","article-title":"Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE","volume":"280","author":"Wautier","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cbi.2011.01.024_bib0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1172\/JCI32703","article-title":"Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE\u2212\/\u2212 mice","volume":"118","author":"Harja","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.cbi.2011.01.024_bib0045","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.2337\/db09-0375","article-title":"Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue","volume":"58","author":"Baba","year":"2009","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.cbi.2011.01.024_bib0050","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2337\/diabetes.55.04.06.db05-0932","article-title":"Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells","volume":"55","author":"Srivastava","year":"2006","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.cbi.2011.01.024_bib0055","doi-asserted-by":"crossref","first-page":"H1586","DOI":"10.1152\/ajpheart.00867.2008","article-title":"Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke","volume":"296","author":"Conklin","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.cbi.2011.01.024_bib0060","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","article-title":"Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts","volume":"4","author":"Park","year":"1998","journal-title":"Nat. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.cbi.2011.01.024_bib0065","first-page":"B65","article-title":"Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications","volume":"22","author":"Friedman","year":"1999","journal-title":"Diabetes Care"},{"issue":"36","key":"10.1016\/j.cbi.2011.01.024_bib0070","doi-asserted-by":"crossref","first-page":"21597","DOI":"10.1016\/S0021-9258(20)88225-8","article-title":"Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process","volume":"264","author":"Sell","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.cbi.2011.01.024_bib0075","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM199109193251202","article-title":"Advanced glycosylation end products in patients with diabetic nephropathy","volume":"325","author":"Makita","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.cbi.2011.01.024_bib0080","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1073\/pnas.90.14.6434","article-title":"Lipid advanced glycosylation: pathway for lipid oxidation in vivo","volume":"90","author":"Bucala","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.cbi.2011.01.024_bib0085","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1016\/S0021-9258(18)42741-X","article-title":"Immunochemical detection of advanced glycosylation end products in vivo","volume":"267","author":"Makita","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.cbi.2011.01.024_bib0090","doi-asserted-by":"crossref","first-page":"11555","DOI":"10.1073\/pnas.88.24.11555","article-title":"Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy","volume":"88","author":"Hammes","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.cbi.2011.01.024_bib0095","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1016\/S0021-9258(19)84914-1","article-title":"Aging of proteins: immunological detection of a glucose-derived pyrrole formed during maillard reaction in vivo","volume":"264","author":"Hayase","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cbi.2011.01.024_bib0100","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.ATV.15.5.571","article-title":"Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits","volume":"15","author":"Palinski","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.cbi.2011.01.024_bib0105","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/CIRCRESAHA.110.225698","article-title":"Endoplasmic reticulum stress and inflammation in obesity and diabetes","volume":"107","author":"Hummasti","year":"2010","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.cbi.2011.01.024_bib0110","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1096\/fj.09-151340","article-title":"JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction","volume":"24","author":"Solinas","year":"2010","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.cbi.2011.01.024_bib0115","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.cbi.2011.01.024_bib0120","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/CIRCRESAHA.106.142851","article-title":"Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity","volume":"100","author":"Kim","year":"2007","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.cbi.2011.01.024_bib0125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1050-1738(99)00016-X","article-title":"Current status of acrolein as a lipid peroxidation product","volume":"9","author":"Uchida","year":"1999","journal-title":"Trends Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.cbi.2011.01.024_bib0130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1172\/JCI119176","volume":"99","author":"Anderson","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cbi.2011.01.024_bib0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/ATVBAHA.108.164723","article-title":"Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice","volume":"29","author":"Kato","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"43","key":"10.1016\/j.cbi.2011.01.024_bib0140","doi-asserted-by":"crossref","first-page":"36386","DOI":"10.1074\/jbc.M508169200","article-title":"Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I","volume":"280","author":"Shao","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.cbi.2011.01.024_bib0145","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diab.36.7.813","article-title":"Increased vascular permeability in spontaneously diabetic BB\/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration","volume":"36","author":"Williamson","year":"1987","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.cbi.2011.01.024_bib0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0891-6632(88)90020-7","article-title":"Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat","volume":"2","author":"McCaleb","year":"1988","journal-title":"J. Diabetes Complicat."},{"issue":"6 Pt 2","key":"10.1016\/j.cbi.2011.01.024_bib0155","first-page":"F1000","article-title":"Sorbinil prevents glomerular hyperperfusion in diabetic rats","volume":"256","author":"Bank","year":"1989","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.cbi.2011.01.024_bib0160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00405080","article-title":"The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus","volume":"34","author":"Chang","year":"1991","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.cbi.2011.01.024_bib0165","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/diab.38.10.1258","article-title":"Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors","volume":"38","author":"Tilton","year":"1989","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.cbi.2011.01.024_bib0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2337\/diab.40.4.465","article-title":"Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats","volume":"40","author":"Goldfarb","year":"1991","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.cbi.2011.01.024_bib0175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1139\/o96-038","article-title":"Prevention of early glomerulopathy with tolrestat in the streptozotocin-induced diabetic rat","volume":"74","author":"Donnelly","year":"1996","journal-title":"Biochem. Cell Biol."},{"issue":"7","key":"10.1016\/j.cbi.2011.01.024_bib0180","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2337\/diab.38.7.839","article-title":"Effects of sorbinil on glomerular structure and function in long-term-diabetic rats","volume":"38","author":"Mauer","year":"1989","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.cbi.2011.01.024_bib0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0002-9610(05)80250-8","article-title":"Aldose reductase inhibition by ponalrestat (statil) does not prevent proteinuria in long-term diabetic rats","volume":"7","author":"Reddi","year":"1993","journal-title":"J. Diabetes Complicat."},{"issue":"1","key":"10.1016\/j.cbi.2011.01.024_bib0190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S1056-8727(98)00015-4","article-title":"Aldose reductase and the development of renal disease in diabetic dogs","volume":"13","author":"Kern","year":"1999","journal-title":"J. Diabetes Complicat."},{"issue":"5","key":"10.1016\/j.cbi.2011.01.024_bib0195","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/diacare.16.5.789","article-title":"Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy","volume":"16","author":"Passariello","year":"1993","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.cbi.2011.01.024_bib0200","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2337\/diab.40.5.527","article-title":"Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 mo of aldose reductase inhibition","volume":"40","author":"Pedersen","year":"1991","journal-title":"Diabetes"},{"issue":"37","key":"10.1016\/j.cbi.2011.01.024_bib0205","doi-asserted-by":"crossref","first-page":"12909","DOI":"10.1021\/bi9804333","article-title":"Kinetic studies of FR-1, a growth factor-inducible aldo-keto reductase","volume":"37","author":"Srivastava","year":"1998","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.cbi.2011.01.024_bib0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1385\/ENDO:18:1:47","article-title":"Prevention of diabetes-induced albuminuria in transgenic rats overexpressing human aldose reductase","volume":"18","author":"Ng","year":"2002","journal-title":"Endocrine"},{"key":"10.1016\/j.cbi.2011.01.024_bib0215","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1046\/j.1523-1755.2000.07702.x","article-title":"Aldose reductase and the role of the polyol pathway in diabetic nephropathy","volume":"77","author":"Dunlop","year":"2000","journal-title":"Kidney Int. Suppl."},{"issue":"5","key":"10.1016\/j.cbi.2011.01.024_bib0220","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCRESAHA.109.212217","article-title":"The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature","volume":"106","author":"Yan","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2011.01.024_bib0225","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1196\/annals.1333.056","article-title":"Dietary bread crust advanced glycation end products bind to the receptor for AGEs in HEK-293 kidney cells but are rapidly excreted after oral administration to healthy and subtotally nephrectomized rats","volume":"1043","author":"Somoza","year":"2005","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.cbi.2011.01.024_bib0230","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.ATV.21.6.905","article-title":"Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice","volume":"21","author":"Kislinger","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.cbi.2011.01.024_bib0235","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.2337\/db09-1766","article-title":"Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse","volume":"59","author":"Reiniger","year":"2010","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.cbi.2011.01.024_bib0240","doi-asserted-by":"crossref","first-page":"F763","DOI":"10.1152\/ajprenal.00591.2009","article-title":"Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy","volume":"298","author":"Tan","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279711000482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279711000482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:25:47Z","timestamp":1757856347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279711000482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":48,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0009279711000482"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2011.01.024","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE)","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2011.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}